Portfolio company
Pencil Biosciences
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
Deep TechDigital Health
About
The company develops a synthetic gene editing platform for researchers and healthcare providers treating patients with oncology and genetic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.